Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pet Veterinary Drug Market Growth 2022-2028

  • LP 4919245
  • 102 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pet Veterinary Drug will have significant change from previous year. According to our (LP Information) latest study, the global Pet Veterinary Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pet Veterinary Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Pet Veterinary Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pet Veterinary Drug market, reaching US$ million by the year 2028. As for the Europe Pet Veterinary Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Pet Veterinary Drug players cover Boehringer Ingelheim International GmbH, Zoetis Animal Healthcare, Bayer AG, and Merck Animal Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet Veterinary Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Anti-Infectives

Anti-Inflammatory

Parasiticides

Analgesics

Sedatives

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Veterinary Hospitals

Veterinary Clinics

Drug Stores

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Boehringer Ingelheim International GmbH

Zoetis Animal Healthcare

Bayer AG

Merck Animal Health

Elanco Animal Health Inc.

Virbac Group

Ceva

Dechra Pharmaceuticals Plc

Vetoquinol

Orion Corporation

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pet Veterinary Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pet Veterinary Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pet Veterinary Drug by Country/Region, 2017, 2022 & 2028

2.2 Pet Veterinary Drug Segment by Type

2.2.1 Anti-Infectives

2.2.2 Anti-Inflammatory

2.2.3 Parasiticides

2.2.4 Analgesics

2.2.5 Sedatives

2.2.6 Others

2.3 Pet Veterinary Drug Sales by Type

2.3.1 Global Pet Veterinary Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Pet Veterinary Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pet Veterinary Drug Sale Price by Type (2017-2022)

2.4 Pet Veterinary Drug Segment by Application

2.4.1 Veterinary Hospitals

2.4.2 Veterinary Clinics

2.4.3 Drug Stores

2.5 Pet Veterinary Drug Sales by Application

2.5.1 Global Pet Veterinary Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Pet Veterinary Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pet Veterinary Drug Sale Price by Application (2017-2022)

3 Global Pet Veterinary Drug by Company

3.1 Global Pet Veterinary Drug Breakdown Data by Company

3.1.1 Global Pet Veterinary Drug Annual Sales by Company (2020-2022)

3.1.2 Global Pet Veterinary Drug Sales Market Share by Company (2020-2022)

3.2 Global Pet Veterinary Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Pet Veterinary Drug Revenue by Company (2020-2022)

3.2.2 Global Pet Veterinary Drug Revenue Market Share by Company (2020-2022)

3.3 Global Pet Veterinary Drug Sale Price by Company

3.4 Key Manufacturers Pet Veterinary Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pet Veterinary Drug Product Location Distribution

3.4.2 Players Pet Veterinary Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pet Veterinary Drug by Geographic Region

4.1 World Historic Pet Veterinary Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Pet Veterinary Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pet Veterinary Drug Annual Revenue by Geographic Region

4.2 World Historic Pet Veterinary Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Pet Veterinary Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pet Veterinary Drug Annual Revenue by Country/Region

4.3 Americas Pet Veterinary Drug Sales Growth

4.4 APAC Pet Veterinary Drug Sales Growth

4.5 Europe Pet Veterinary Drug Sales Growth

4.6 Middle East & Africa Pet Veterinary Drug Sales Growth

5 Americas

5.1 Americas Pet Veterinary Drug Sales by Country

5.1.1 Americas Pet Veterinary Drug Sales by Country (2017-2022)

5.1.2 Americas Pet Veterinary Drug Revenue by Country (2017-2022)

5.2 Americas Pet Veterinary Drug Sales by Type

5.3 Americas Pet Veterinary Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pet Veterinary Drug Sales by Region

6.1.1 APAC Pet Veterinary Drug Sales by Region (2017-2022)

6.1.2 APAC Pet Veterinary Drug Revenue by Region (2017-2022)

6.2 APAC Pet Veterinary Drug Sales by Type

6.3 APAC Pet Veterinary Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pet Veterinary Drug by Country

7.1.1 Europe Pet Veterinary Drug Sales by Country (2017-2022)

7.1.2 Europe Pet Veterinary Drug Revenue by Country (2017-2022)

7.2 Europe Pet Veterinary Drug Sales by Type

7.3 Europe Pet Veterinary Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pet Veterinary Drug by Country

8.1.1 Middle East & Africa Pet Veterinary Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pet Veterinary Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Pet Veterinary Drug Sales by Type

8.3 Middle East & Africa Pet Veterinary Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pet Veterinary Drug

10.3 Manufacturing Process Analysis of Pet Veterinary Drug

10.4 Industry Chain Structure of Pet Veterinary Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pet Veterinary Drug Distributors

11.3 Pet Veterinary Drug Customer

12 World Forecast Review for Pet Veterinary Drug by Geographic Region

12.1 Global Pet Veterinary Drug Market Size Forecast by Region

12.1.1 Global Pet Veterinary Drug Forecast by Region (2023-2028)

12.1.2 Global Pet Veterinary Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pet Veterinary Drug Forecast by Type

12.7 Global Pet Veterinary Drug Forecast by Application

13 Key Players Analysis

13.1 Boehringer Ingelheim International GmbH

13.1.1 Boehringer Ingelheim International GmbH Company Information

13.1.2 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Offered

13.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boehringer Ingelheim International GmbH Main Business Overview

13.1.5 Boehringer Ingelheim International GmbH Latest Developments

13.2 Zoetis Animal Healthcare

13.2.1 Zoetis Animal Healthcare Company Information

13.2.2 Zoetis Animal Healthcare Pet Veterinary Drug Product Offered

13.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Zoetis Animal Healthcare Main Business Overview

13.2.5 Zoetis Animal Healthcare Latest Developments

13.3 Bayer AG

13.3.1 Bayer AG Company Information

13.3.2 Bayer AG Pet Veterinary Drug Product Offered

13.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bayer AG Main Business Overview

13.3.5 Bayer AG Latest Developments

13.4 Merck Animal Health

13.4.1 Merck Animal Health Company Information

13.4.2 Merck Animal Health Pet Veterinary Drug Product Offered

13.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck Animal Health Main Business Overview

13.4.5 Merck Animal Health Latest Developments

13.5 Elanco Animal Health Inc.

13.5.1 Elanco Animal Health Inc. Company Information

13.5.2 Elanco Animal Health Inc. Pet Veterinary Drug Product Offered

13.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Elanco Animal Health Inc. Main Business Overview

13.5.5 Elanco Animal Health Inc. Latest Developments

13.6 Virbac Group

13.6.1 Virbac Group Company Information

13.6.2 Virbac Group Pet Veterinary Drug Product Offered

13.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Virbac Group Main Business Overview

13.6.5 Virbac Group Latest Developments

13.7 Ceva

13.7.1 Ceva Company Information

13.7.2 Ceva Pet Veterinary Drug Product Offered

13.7.3 Ceva Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ceva Main Business Overview

13.7.5 Ceva Latest Developments

13.8 Dechra Pharmaceuticals Plc

13.8.1 Dechra Pharmaceuticals Plc Company Information

13.8.2 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Offered

13.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Dechra Pharmaceuticals Plc Main Business Overview

13.8.5 Dechra Pharmaceuticals Plc Latest Developments

13.9 Vetoquinol

13.9.1 Vetoquinol Company Information

13.9.2 Vetoquinol Pet Veterinary Drug Product Offered

13.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Vetoquinol Main Business Overview

13.9.5 Vetoquinol Latest Developments

13.10 Orion Corporation

13.10.1 Orion Corporation Company Information

13.10.2 Orion Corporation Pet Veterinary Drug Product Offered

13.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Orion Corporation Main Business Overview

13.10.5 Orion Corporation Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Pet Veterinary Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pet Veterinary Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Anti-Infectives

Table 4. Major Players of Anti-Inflammatory

Table 5. Major Players of Parasiticides

Table 6. Major Players of Analgesics

Table 7. Major Players of Sedatives

Table 8. Major Players of Others

Table 9. Global Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)

Table 10. Global Pet Veterinary Drug Sales Market Share by Type (2017-2022)

Table 11. Global Pet Veterinary Drug Revenue by Type (2017-2022) & ($ million)

Table 12. Global Pet Veterinary Drug Revenue Market Share by Type (2017-2022)

Table 13. Global Pet Veterinary Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 14. Global Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)

Table 15. Global Pet Veterinary Drug Sales Market Share by Application (2017-2022)

Table 16. Global Pet Veterinary Drug Revenue by Application (2017-2022)

Table 17. Global Pet Veterinary Drug Revenue Market Share by Application (2017-2022)

Table 18. Global Pet Veterinary Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 19. Global Pet Veterinary Drug Sales by Company (2020-2022) & (K Units)

Table 20. Global Pet Veterinary Drug Sales Market Share by Company (2020-2022)

Table 21. Global Pet Veterinary Drug Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Pet Veterinary Drug Revenue Market Share by Company (2020-2022)

Table 23. Global Pet Veterinary Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 24. Key Manufacturers Pet Veterinary Drug Producing Area Distribution and Sales Area

Table 25. Players Pet Veterinary Drug Products Offered

Table 26. Pet Veterinary Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Pet Veterinary Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Pet Veterinary Drug Sales Market Share Geographic Region (2017-2022)

Table 31. Global Pet Veterinary Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Pet Veterinary Drug Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Pet Veterinary Drug Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Pet Veterinary Drug Sales Market Share by Country/Region (2017-2022)

Table 35. Global Pet Veterinary Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Pet Veterinary Drug Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Pet Veterinary Drug Sales by Country (2017-2022) & (K Units)

Table 38. Americas Pet Veterinary Drug Sales Market Share by Country (2017-2022)

Table 39. Americas Pet Veterinary Drug Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Pet Veterinary Drug Revenue Market Share by Country (2017-2022)

Table 41. Americas Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)

Table 42. Americas Pet Veterinary Drug Sales Market Share by Type (2017-2022)

Table 43. Americas Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)

Table 44. Americas Pet Veterinary Drug Sales Market Share by Application (2017-2022)

Table 45. APAC Pet Veterinary Drug Sales by Region (2017-2022) & (K Units)

Table 46. APAC Pet Veterinary Drug Sales Market Share by Region (2017-2022)

Table 47. APAC Pet Veterinary Drug Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Pet Veterinary Drug Revenue Market Share by Region (2017-2022)

Table 49. APAC Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)

Table 50. APAC Pet Veterinary Drug Sales Market Share by Type (2017-2022)

Table 51. APAC Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)

Table 52. APAC Pet Veterinary Drug Sales Market Share by Application (2017-2022)

Table 53. Europe Pet Veterinary Drug Sales by Country (2017-2022) & (K Units)

Table 54. Europe Pet Veterinary Drug Sales Market Share by Country (2017-2022)

Table 55. Europe Pet Veterinary Drug Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Pet Veterinary Drug Revenue Market Share by Country (2017-2022)

Table 57. Europe Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)

Table 58. Europe Pet Veterinary Drug Sales Market Share by Type (2017-2022)

Table 59. Europe Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)

Table 60. Europe Pet Veterinary Drug Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Pet Veterinary Drug Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Pet Veterinary Drug Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Pet Veterinary Drug Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Pet Veterinary Drug Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Pet Veterinary Drug Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Pet Veterinary Drug Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Pet Veterinary Drug Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Pet Veterinary Drug Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Pet Veterinary Drug

Table 70. Key Market Challenges & Risks of Pet Veterinary Drug

Table 71. Key Industry Trends of Pet Veterinary Drug

Table 72. Pet Veterinary Drug Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Pet Veterinary Drug Distributors List

Table 75. Pet Veterinary Drug Customer List

Table 76. Global Pet Veterinary Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Pet Veterinary Drug Sales Market Forecast by Region

Table 78. Global Pet Veterinary Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Pet Veterinary Drug Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Pet Veterinary Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Pet Veterinary Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Pet Veterinary Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Pet Veterinary Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Pet Veterinary Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Pet Veterinary Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Pet Veterinary Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Pet Veterinary Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Pet Veterinary Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Pet Veterinary Drug Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Pet Veterinary Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Pet Veterinary Drug Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Pet Veterinary Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Pet Veterinary Drug Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Pet Veterinary Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Pet Veterinary Drug Revenue Market Share Forecast by Application (2023-2028)

Table 96. Boehringer Ingelheim International GmbH Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 97. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Offered

Table 98. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 99. Boehringer Ingelheim International GmbH Main Business

Table 100. Boehringer Ingelheim International GmbH Latest Developments

Table 101. Zoetis Animal Healthcare Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 102. Zoetis Animal Healthcare Pet Veterinary Drug Product Offered

Table 103. Zoetis Animal Healthcare Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 104. Zoetis Animal Healthcare Main Business

Table 105. Zoetis Animal Healthcare Latest Developments

Table 106. Bayer AG Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 107. Bayer AG Pet Veterinary Drug Product Offered

Table 108. Bayer AG Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 109. Bayer AG Main Business

Table 110. Bayer AG Latest Developments

Table 111. Merck Animal Health Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 112. Merck Animal Health Pet Veterinary Drug Product Offered

Table 113. Merck Animal Health Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 114. Merck Animal Health Main Business

Table 115. Merck Animal Health Latest Developments

Table 116. Elanco Animal Health Inc. Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 117. Elanco Animal Health Inc. Pet Veterinary Drug Product Offered

Table 118. Elanco Animal Health Inc. Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 119. Elanco Animal Health Inc. Main Business

Table 120. Elanco Animal Health Inc. Latest Developments

Table 121. Virbac Group Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 122. Virbac Group Pet Veterinary Drug Product Offered

Table 123. Virbac Group Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 124. Virbac Group Main Business

Table 125. Virbac Group Latest Developments

Table 126. Ceva Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 127. Ceva Pet Veterinary Drug Product Offered

Table 128. Ceva Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 129. Ceva Main Business

Table 130. Ceva Latest Developments

Table 131. Dechra Pharmaceuticals Plc Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 132. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Offered

Table 133. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 134. Dechra Pharmaceuticals Plc Main Business

Table 135. Dechra Pharmaceuticals Plc Latest Developments

Table 136. Vetoquinol Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 137. Vetoquinol Pet Veterinary Drug Product Offered

Table 138. Vetoquinol Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 139. Vetoquinol Main Business

Table 140. Vetoquinol Latest Developments

Table 141. Orion Corporation Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors

Table 142. Orion Corporation Pet Veterinary Drug Product Offered

Table 143. Orion Corporation Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 144. Orion Corporation Main Business

Table 145. Orion Corporation Latest Developments

List of Figures

Figure 1. Picture of Pet Veterinary Drug

Figure 2. Pet Veterinary Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pet Veterinary Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Pet Veterinary Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pet Veterinary Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Anti-Infectives

Figure 10. Product Picture of Anti-Inflammatory

Figure 11. Product Picture of Parasiticides

Figure 12. Product Picture of Analgesics

Figure 13. Product Picture of Sedatives

Figure 14. Product Picture of Others

Figure 15. Global Pet Veterinary Drug Sales Market Share by Type in 2021

Figure 16. Global Pet Veterinary Drug Revenue Market Share by Type (2017-2022)

Figure 17. Pet Veterinary Drug Consumed in Veterinary Hospitals

Figure 18. Global Pet Veterinary Drug Market: Veterinary Hospitals (2017-2022) & (K Units)

Figure 19. Pet Veterinary Drug Consumed in Veterinary Clinics

Figure 20. Global Pet Veterinary Drug Market: Veterinary Clinics (2017-2022) & (K Units)

Figure 21. Pet Veterinary Drug Consumed in Drug Stores

Figure 22. Global Pet Veterinary Drug Market: Drug Stores (2017-2022) & (K Units)

Figure 23. Global Pet Veterinary Drug Sales Market Share by Application (2017-2022)

Figure 24. Global Pet Veterinary Drug Revenue Market Share by Application in 2021

Figure 25. Pet Veterinary Drug Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Pet Veterinary Drug Revenue Market Share by Company in 2021

Figure 27. Global Pet Veterinary Drug Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Pet Veterinary Drug Revenue Market Share by Geographic Region in 2021

Figure 29. Global Pet Veterinary Drug Sales Market Share by Region (2017-2022)

Figure 30. Global Pet Veterinary Drug Revenue Market Share by Country/Region in 2021

Figure 31. Americas Pet Veterinary Drug Sales 2017-2022 (K Units)

Figure 32. Americas Pet Veterinary Drug Revenue 2017-2022 ($ Millions)

Figure 33. APAC Pet Veterinary Drug Sales 2017-2022 (K Units)

Figure 34. APAC Pet Veterinary Drug Revenue 2017-2022 ($ Millions)

Figure 35. Europe Pet Veterinary Drug Sales 2017-2022 (K Units)

Figure 36. Europe Pet Veterinary Drug Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Pet Veterinary Drug Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Pet Veterinary Drug Revenue 2017-2022 ($ Millions)

Figure 39. Americas Pet Veterinary Drug Sales Market Share by Country in 2021

Figure 40. Americas Pet Veterinary Drug Revenue Market Share by Country in 2021

Figure 41. United States Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Pet Veterinary Drug Sales Market Share by Region in 2021

Figure 46. APAC Pet Veterinary Drug Revenue Market Share by Regions in 2021

Figure 47. China Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Pet Veterinary Drug Sales Market Share by Country in 2021

Figure 54. Europe Pet Veterinary Drug Revenue Market Share by Country in 2021

Figure 55. Germany Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Pet Veterinary Drug Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Pet Veterinary Drug Revenue Market Share by Country in 2021

Figure 62. Egypt Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Pet Veterinary Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Pet Veterinary Drug in 2021

Figure 68. Manufacturing Process Analysis of Pet Veterinary Drug

Figure 69. Industry Chain Structure of Pet Veterinary Drug

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390